Wednesday, March 19, 2025 at 7:00 AM
This grand round has already taken place.
Online Streaming Available
March 19th, 2025 1.00 AMA PRA Category 1 Credit Hours
Description
Esketamine (Spravato) is currently FDA-approved for use in management of treatment-resistant depression. Recently, investigation into the benefits of esketamine as an anesthetic agent has gained traction. This presentation explores the evolving applications of esketamine in anesthesiology.
Streams
| Name | |
|---|---|
| You must be signed in to view streams. Click here to sign into your Stony Brook Medicine CME Account. |
Dates and Times
Start: 3/19/2025 7:00 AM
End: 3/19/2025 8:00 AM
Objectives
Understand the pharmacology and mechanism of action of esketamine
Analyze the evolving clinical applications of esketamine
Review clinical trials and research milestones
Speakers
Location
Stony Brook Medicine
HSC Level 3, lecture hall 5
HSC, Level 3. :Lecture Hall 5
Stony Brook, NY 11794
Accreditation
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Disclosure
The planners, speakers and reviewers have no relevant financial relationship with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Christine Fogarty
Department: Anesthesiology
Phone: (631) 444-1614
Email: christinedfogarty@stonybrookmedicine.edu